Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if FULC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
34 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 86 days ago
Red flags: 2
155 filers reported a long position in FULC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $32.3M | 8.8M | +63.7% |
| EcoR1 Capital, LLC | $24M | 6.5M | New |
| TANG CAPITAL MANAGEMENT LLC | $23.9M | 6.5M | New |
| Nantahala Capital Management, LLC | $20M | 5.5M | +79.5% |
| MONTANOVA CAPITAL, LLC | $13.5M | 3.7M | -43.9% |
| D. E. Shaw & Co., Inc. | $11.1M | 3M | +87.5% |
| CITADEL ADVISORS LLC | $9.9M | 2.7M | +109.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.9M | 2.7M | +0.2% |
| JANE STREET GROUP, LLC | $8.1M | 2.2M | +614.4% |
| STATE STREET CORP | $7.5M | 2M | +31.4% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.